Ara
Toplam kayıt 6, listelenen: 1-6
Is bioresorbable vascular scaffold acute recoil affected by baseline renal function and scaffold selection?
(Elsevier Ireland Ltd., 2016)
Objective: The aim of the present study was to investigate the relationship between glomerular filtration rate (GFR) and acute post-scaffold recoil (PSR) in patients undergoing bioresorbable scaffold (BVS) implantation. ...
Predicting ventricular arrhythmias in cardiac resynchronization therapy: The impact of persistent electrical dyssynchrony
(Wiley, 2016)
BackgroundAlthough response to cardiac resynchronization therapy (CRT) has been conventionally assessed with left ventricular volume reduction, ventricular arrhythmias (ventricular tachycardia/ventricular fibrillation ...
Real-life data regarding acute procedural success and 1-year clinical outcome of desolve bioresorbable scaffolds
(Wiley, 2017)
Objectives: We aimed to evaluate the peri-procedural success of DESolve bio-resorbable scaffolds (BRSs) and analyzed real-life data about major cardiac events during 1-year follow-up. Background: There is little information ...
Assessment of repolarization abnormalities in baseline electrocardiograms of patients with myocarditis
(Tübitak Scientific and Technological Research Council of Turkey, 2017)
Background/aim: Myocarditis in the acute phase usually presents with sinus tachycardia but many other arrhythmias might be seen as well. In this study we aimed to investigate repolarization abnormalities in baseline ECG ...
Assessment of energy expenditure, physical activity and sleep pattern in patients with frequent symptomatic ventricular ectopic beats
(Masson Editeur, 2016)
Background. Ventricular ectopic beats (VEBs) are considered as benign ventricular arrhythmias in patients without structural heart disease. However, symptomatic frequent VEBs can adversely affect energy metabolism. The ...
Long-term outcomes of patients presenting with acute coronary syndrome and implanted with bioresorbable scaffold
(Yuzuncu Yıl University Faculty of Medicine, 2022)
A bioresorbable scaffold (BRS) has been used in the latest stages of stent technology and is a less-known material than drug-eluting stents (DES). In this study, we aimed to evaluate the long-term clinical outcomes of BRS ...